Visible changes on the scale typically begin within the first month, with continued progress over several months as your plan is optimized
Yes, GLP-1 drugs can lead to significant muscle lossespecially without the right nutrition and exercise support
Key Differences : Weekly injections (e.g., Ozempic, Mounjaro) are more convenient for many
How much weight can you lose on Mounjaro
Triple Receptor Mechanism Retatrutide is the first molecule to simultaneously engage all three receptors implicated in energy balance and body weight regulation: GLP-1 receptor: Reduces appetite, slows gastric emptying, improves glycemic control the same pathway as semaglutide (Ozempic/Wegovy) GIP receptor: Enhances insulin secretion and may contribute to fat mobilization the same dual pathway as tirzepatide (Mounjaro/Zepbound) Glucagon receptor: Increases energy expenditure, promotes hepatic fat oxidation, and drives thermogenesis a pathway unique to retatrutide among obesity therapeutics Clinical Significance In the Phase 2 trial published in the New England Journal of Medicine (2023), participants receiving the highest dose of retatrutide achieved a mean body weight reduction of 24.2% at 48 weeks with some participants losing over 30% of their body weight

Beyond the saturation point, additional CJC-1295 Ipamorelin dosage produces little additional IGF-1 elevation while increasing compound consumption and potential side effects